UPDATE: Benchmark Downgrades ICU Medical to Hold on Valuation

In a report published Thursday, Benchmark Company analyst James Terwilliger downgraded the rating on ICU Medical (NASDAQ: ICUI ) from Buy to Hold, but reiterated the $69.00 price target. In the report, Terwilliger noted, “We are lowering our recommendation to Hold from Buy based on valuation as ICU Medical has